Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Ischemic Heart Disease

Free Subscription Articles published in J Mol Cell Cardiol Retrieve available abstracts of 68 articles: HTML format

Single Articles

November 2023
1. MANGIONE MC, Wen J, Cao DJ
   Mechanistic target of rapamycin in regulating macrophage function in inflammatory cardiovascular diseases.
   J Mol Cell Cardiol. 2023;186:111-124.
   PubMed     Abstract available
   
   
   
2. LI J, Gong Y, Wang Y, Huang H, et al
   Classification of regulatory T cells and their role in myocardial ischemia-reperfusion injury.
   J Mol Cell Cardiol. 2023;186:94-106.
   PubMed     Abstract available
   
   
   
3. MALLIKARJUN V, Yin B, Caggiano LR, Blimbaum S, et al
   Automated spatially targeted optical micro proteomics identifies fibroblast- and macrophage-specific regulation of myocardial infarction scar maturation in rats.
   J Mol Cell Cardiol. 2023;186:1-15.
   PubMed     Abstract available
   
   
   
4. ZHANG W, Dong E, Zhang J, Zhang Y, et al
   CaMKII, 'jack of all trades' in inflammation during cardiac ischemia/reperfusion injury.
   J Mol Cell Cardiol. 2023;184:48-60.
   PubMed     Abstract available
   
   
   
5. WU R, Hu X, Wang J
   Current optimized strategies for stem cell-derived extracellular vesicle/exosomes in cardiac repair.
   J Mol Cell Cardiol. 2023;184:13-25.
   PubMed     Abstract available
   
   
   September 2023
6. LIU Z, Liu Z, Xu X, Zhou Y, et al
   Role of ventrolateral part of ventromedial hypothalamus in post-myocardial infarction cardiac dysfunction induced by sympathetic nervous system.
   J Mol Cell Cardiol. 2023 Sep 30:S0022-2828(23)00154.
   PubMed     Abstract available
   
   
   
7. MANASERH IH, Bledzka KM, Ampong I, Junker A, et al
   A cardiac amino-terminal GRK2 peptide inhibits insulin resistance yet enhances maladaptive cardiovascular and brown adipose tissue remodeling in females during diet-induced obesity.
   J Mol Cell Cardiol. 2023 Sep 13:S0022-2828(23)00140.
   PubMed     Abstract available
   
   
   
8. QIN D, Jia XF, Hanna A, Lee J, et al
   BAK contributes critically to necrosis and infarct generation during reperfused myocardial infarction.
   J Mol Cell Cardiol. 2023 Sep 12:S0022-2828(23)00143.
   PubMed     Abstract available
   
   
   
9. CASIN KM, Bustamante M, Amanakis G, Sun J, et al
   Loss of cyclophilin D prolyl isomerase activity desensitizes mitochondrial permeability transition pore opening in isolated cardiac mitochondria, but does not protect in myocardial ischemia-reperfusion injury.
   J Mol Cell Cardiol. 2023;183:67-69.
   PubMed    
   
   
   
10. XIAO Z, Wei X, Li M, Yang K, et al
    Myeloid-specific deletion of Capns1 attenuates myocardial infarction injury via restoring mitochondrial function and inhibiting inflammasome activation.
    J Mol Cell Cardiol. 2023;183:54-66.
    PubMed     Abstract available
    
    
    
11. MENG Z, Liang B, Wu Y, Liu C, et al
    Hypoadiponectinemia-induced upregulation of microRNA449b downregulating Nrf-1 aggravates cardiac ischemia-reperfusion injury in diabetic mice.
    J Mol Cell Cardiol. 2023;182:1-14.
    PubMed     Abstract available
    
    
    July 2023
12. DYKES IM, van Bueren KL, Scambler PJ
    Corrigendum to "HIC2 regulates isoform switching during maturation of the cardiovascular system" [Journal of Molecular and Cellular Cardiology volume 114 (2018) P29-37/ https://doi.org/10.1016/j.yjmcc.2017.10.007].
    J Mol Cell Cardiol. 2023 Jul 28:S0022-2828(23)00125.
    PubMed    
    
    
    June 2023
13. SCHMECKPEPER J, Kim K, George SA, Blackwell D, et al
    RyR2 inhibition with dantrolene is antiarrhythmic, prevents further pathological remodeling, and improves cardiac function in chronic ischemic heart disease.
    J Mol Cell Cardiol. 2023 Jun 5:S0022-2828(23)00101.
    PubMed     Abstract available
    
    
    
14. JIN X, Meletiou A, Chung J, Tilunaite A, et al
    InsP(3)R-RyR channel crosstalk augments sarcoplasmic reticulum Ca(2+) release and arrhythmogenic activity in post-MI pig cardiomyocytes.
    J Mol Cell Cardiol. 2023;179:47-59.
    PubMed     Abstract available
    
    
    May 2023
15. BRLECIC PE, Bonham CA, Rosengart TK, Mathison M, et al
    Direct cardiac reprogramming: A new technology for cardiac repair.
    J Mol Cell Cardiol. 2023;178:51-58.
    PubMed     Abstract available
    
    
    
16. YAMADA Y, Sadahiro T, Ieda M
    Development of direct cardiac reprogramming for clinical applications.
    J Mol Cell Cardiol. 2023;178:1-8.
    PubMed     Abstract available
    
    
    April 2023
17. LI R, Xiang C, Li Y, Nie Y, et al
    Targeting immunoregulation for cardiac regeneration.
    J Mol Cell Cardiol. 2023;177:1-8.
    PubMed     Abstract available
    
    
    March 2023
18. GARRY GA, Olson EN
    Reprogramming of cardiac cell fate as a therapeutic strategy for ischemic heart disease.
    J Mol Cell Cardiol. 2023 Mar 28:S0022-2828(23)00058.
    PubMed     Abstract available
    
    
    
19. FUJII S, Kobayashi S, Chang Y, Nawata J, et al
    RyR2-targeting therapy prevents left ventricular remodeling and ventricular tachycardia in post-infarction heart failure.
    J Mol Cell Cardiol. 2023 Mar 22:S0022-2828(23)00052.
    PubMed     Abstract available
    
    
    
20. SAYEGH MN, Cooney KA, Han WM, Cicka M, et al
    Hydrogel delivery of purinergic enzymes improves cardiac ischemia/reperfusion injury.
    J Mol Cell Cardiol. 2023;176:98-109.
    PubMed     Abstract available
    
    
    February 2023
21. DING Z, Tan K, Alter C, Temme S, et al
    Cardiac injection of USSC boosts remuscularization of the infarcted heart by shaping the T-cell response.
    J Mol Cell Cardiol. 2023;175:29-43.
    PubMed     Abstract available
    
    
    January 2023
22. CAO Y, Palpant NJ
    The ins and outs of cellular pH during cardiac ischemia.
    J Mol Cell Cardiol. 2023;174:133-134.
    PubMed    
    
    
    
23. ZHANG M, Wang C, Wang R, Xu J, et al
    Adenosine kinase promotes post-infarction cardiac repair by epigenetically maintaining reparative macrophage phenotype.
    J Mol Cell Cardiol. 2023;174:88-100.
    PubMed     Abstract available
    
    
    
24. ROBICHAUX DJ, Harata M, Murphy E, Karch J, et al
    Mitochondrial permeability transition pore-dependent necrosis.
    J Mol Cell Cardiol. 2023;174:47-55.
    PubMed     Abstract available
    
    
    December 2022
25. LI Y, Xiong Z, Jiang Y, Zhou H, et al
    Klf4 deficiency exacerbates myocardial ischemia/reperfusion injury in mice via enhancing ROCK1/DRP1 pathway-dependent mitochondrial fission.
    J Mol Cell Cardiol. 2022;174:115-132.
    PubMed     Abstract available
    
    
    
26. ABOUMSALLEM JP, Shi C, De Wit S, Markousis-Mavrogenis G, et al
    Multi-omics analyses identify molecular signatures with prognostic values in different heart failure aetiologies.
    J Mol Cell Cardiol. 2022;175:13-28.
    PubMed     Abstract available
    
    
    
27. FUNK F, Kronenbitter A, Isic M, Flocke V, et al
    Diabetes disturbs functional adaptation of the remote myocardium after ischemia/reperfusion.
    J Mol Cell Cardiol. 2022;173:47-60.
    PubMed     Abstract available
    
    
    November 2022
28. KOBAYASHI H, Tohyama S, Kanazawa H, Ichimura H, et al
    Intracoronary transplantation of pluripotent stem cell-derived cardiomyocytes: Inefficient procedure for cardiac regeneration.
    J Mol Cell Cardiol. 2022 Nov 17:S0022-2828(22)00564.
    PubMed     Abstract available
    
    
    
29. RICKETTS SN, Qian L
    The heart of cardiac reprogramming: The cardiac fibroblasts.
    J Mol Cell Cardiol. 2022;172:90-99.
    PubMed     Abstract available
    
    
    October 2022
30. GAO Y, Shi H, Dong Z, Zhang F, et al
    Current knowledge of pyroptosis in heart diseases.
    J Mol Cell Cardiol. 2022;171:81-89.
    PubMed     Abstract available
    
    
    
31. CHEN B, Li R, Hernandez SC, Hanna A, et al
    Differential effects of Smad2 and Smad3 in regulation of macrophage phenotype and function in the infarcted myocardium.
    J Mol Cell Cardiol. 2022;171:1-15.
    PubMed     Abstract available
    
    
    September 2022
32. YANG J, Tong T, Zhu C, Zhou M, et al
    Peli1 contributes to myocardial ischemia/reperfusion injury by impairing autophagy flux via its E3 ligase mediated ubiquitination of P62.
    J Mol Cell Cardiol. 2022;173:30-46.
    PubMed     Abstract available
    
    
    
33. CAO Y, Luo F, Peng J, Fang Z, et al
    KMT2B-dependent RFK transcription activates the TNF-alpha/NOX2 pathway and enhances ferroptosis caused by myocardial ischemia-reperfusion.
    J Mol Cell Cardiol. 2022 Sep 23. pii: S0022-2828(22)00528.
    PubMed     Abstract available
    
    
    
34. HAPKE N, Heinrichs M, Ashour D, Vogel E, et al
    Identification of a novel cardiac epitope triggering T-cell responses in patients with myocardial infarction.
    J Mol Cell Cardiol. 2022 Sep 16. pii: S0022-2828(22)00520.
    PubMed     Abstract available
    
    
    
35. QI L, Wang Y, Hu H, Li P, et al
    m(6)A methyltransferase METTL3 participated in sympathetic neural remodeling post-MI via the TRAF6/NF-kappaB pathway and ROS production.
    J Mol Cell Cardiol. 2022;170:87-99.
    PubMed     Abstract available
    
    
    
36. ZHU W, Sun J, Bishop SP, Sadek H, et al
    Turning back the clock: A concise viewpoint of cardiomyocyte cell cycle activation for myocardial regeneration and repair.
    J Mol Cell Cardiol. 2022;170:15-21.
    PubMed     Abstract available
    
    
    August 2022
37. LI Y, Li C, Liu Q, Wang L, et al
    Loss of Acta2 in cardiac fibroblasts does not prevent the myofibroblast differentiation or affect the cardiac repair after myocardial infarction.
    J Mol Cell Cardiol. 2022;171:117-132.
    PubMed     Abstract available
    
    
    July 2022
38. FERRERO KM, Koch WJ
    GRK2 in cardiovascular disease and its potential as a therapeutic target.
    J Mol Cell Cardiol. 2022;172:14-23.
    PubMed     Abstract available
    
    
    June 2022
39. EBERHARDT DR, Lee SH, Yin X, Balynas AM, et al
    EFHD1 ablation inhibits cardiac mitoflash activation and protects cardiomyocytes from ischemia.
    J Mol Cell Cardiol. 2022;167:1-14.
    PubMed     Abstract available
    
    
    May 2022
40. KHANNA A, Ayan B, Undieh AA, Yang YP, et al
    Advances in three-dimensional bioprinted stem cell-based tissue engineering for cardiovascular regeneration.
    J Mol Cell Cardiol. 2022;169:13-27.
    PubMed     Abstract available
    
    
    
41. CHENG G, Zhu D, Huang K, Caranasos TG, et al
    Minimally invasive delivery of a hydrogel-based exosome patch to prevent heart failure.
    J Mol Cell Cardiol. 2022 May 3. pii: S0022-2828(22)00085.
    PubMed     Abstract available
    
    
    
42. CHEN BR, Wei TW, Tang CP, Sun JT, et al
    MNK2-eIF4E axis promotes cardiac repair in the infarcted mouse heart by activating cyclin D1.
    J Mol Cell Cardiol. 2022;166:91-106.
    PubMed     Abstract available
    
    
    April 2022
43. MOTURI S, Ghosh-Choudhary SK, Finkel T
    Cardiovascular disease and the biology of aging.
    J Mol Cell Cardiol. 2022;167:109-117.
    PubMed     Abstract available
    
    
    
44. KONG D, Yu Y
    Prostaglandin D2 signaling and cardiovascular homeostasis.
    J Mol Cell Cardiol. 2022;167:97-105.
    PubMed     Abstract available
    
    
    
45. JAMAIYAR A, Juguilon C, Wan W, Richardson D, et al
    The essential role for endothelial cell sprouting in coronary collateral growth.
    J Mol Cell Cardiol. 2022;165:158-171.
    PubMed     Abstract available
    
    
    March 2022
46. WANG YL, Bai L, Shi XR, Zhu H, et al
    Osteoblast MR deficiency protects against adverse ventricular remodeling after myocardial infarction.
    J Mol Cell Cardiol. 2022 Mar 18. pii: S0022-2828(22)00047.
    PubMed     Abstract available
    
    
    February 2022
47. MIDGETT DE, Thorn SL, Ahn SS, Uman S, et al
    CineCT platform for in vivo and ex vivo measurement of 3D high resolution Lagrangian strains in the left ventricle following myocardial infarction and intramyocardial delivery of theranostic hydrogel.
    J Mol Cell Cardiol. 2022 Feb 25. pii: S0022-2828(22)00032.
    PubMed     Abstract available
    
    
    January 2022
48. QIN Z, Gao L, Lin G, Zhu H, et al
    The nuclear receptor co-repressor 1 is a novel cardioprotective factor against acute myocardial ischemia-reperfusion injury.
    J Mol Cell Cardiol. 2022 Jan 23. pii: S0022-2828(22)00009.
    PubMed     Abstract available
    
    
    December 2021
49. CHEN CL, Kang PT, Zhang L, Xiao K, et al
    Reperfusion mediates heme impairment with increased protein cysteine sulfonation of mitochondrial complex III in the post-ischemic heart.
    J Mol Cell Cardiol. 2021;161:23-38.
    PubMed     Abstract available
    
    
    November 2021
50. ZHU Y, Woo YJ
    Photosynthetic symbiotic therapeutics - An innovative, effective treatment for ischemic cardiovascular diseases.
    J Mol Cell Cardiol. 2021 Nov 20. pii: S0022-2828(21)00222.
    PubMed     Abstract available
    
    
    
51. LANTZ C, Becker A, Thorp EB
    Can polarization of macrophage metabolism enhance cardiac regeneration?
    J Mol Cell Cardiol. 2021;160:87-96.
    PubMed     Abstract available
    
    
    October 2021
52. CAGGIANO LR, Holmes JW, Witzenburg CM
    Individual variability in animal-specific hemodynamic compensation following myocardial infarction.
    J Mol Cell Cardiol. 2021 Oct 28. pii: S0022-2828(21)00207.
    PubMed     Abstract available
    
    
    
53. PALIOURA D, Lazou A, Drosatos K
    Kruppel-like factor (KLF)5: An emerging foe of cardiovascular health.
    J Mol Cell Cardiol. 2021 Oct 12. pii: S0022-2828(21)00193.
    PubMed     Abstract available
    
    
    
54. JEZEK F, Randall EB, Carlson BE, Beard DA, et al
    Systems analysis of the mechanisms governing the cardiovascular response to changes in posture and in peripheral demand during exercise.
    J Mol Cell Cardiol. 2021 Oct 6. pii: S0022-2828(21)00191.
    PubMed     Abstract available
    
    
    
55. WANG X, Wan TC, Lauth A, Purdy AL, et al
    Conditional depletion of the acetyltransferase Tip60 protects against the damaging effects of myocardial infarction.
    J Mol Cell Cardiol. 2021 Oct 2. pii: S0022-2828(21)00189.
    PubMed     Abstract available
    
    
    
56. CHEN G, Phan V, Luo X, Cao DJ, et al
    The mechanistic target of rapamycin complex 1 critically regulates the function of mononuclear phagocytes and promotes cardiac remodeling in acute ischemia.
    J Mol Cell Cardiol. 2021;159:62-79.
    PubMed     Abstract available
    
    
    September 2021
57. KOELWYN GJ, Aboumsallem JP, Moore KJ, de Boer RA, et al
    Reverse cardio-oncology: Exploring the effects of cardiovascular disease on cancer pathogenesis.
    J Mol Cell Cardiol. 2021 Sep 25. pii: S0022-2828(21)00180.
    PubMed     Abstract available
    
    
    
58. HSU WT, Tseng YH, Jui HY, Kuo CC, et al
    5-Methoxytryptophan attenuates postinfarct cardiac injury by controlling oxidative stress and immune activation.
    J Mol Cell Cardiol. 2021;158:101-114.
    PubMed     Abstract available
    
    
    
59. BIAN Y, Pang P, Li X, Yu S, et al
    CircHelz activates NLRP3 inflammasome to promote myocardial injury by sponging miR-133a-3p in mouse ischemic heart.
    J Mol Cell Cardiol. 2021;158:128-139.
    PubMed     Abstract available
    
    
    June 2021
60. PATEREK A, Okninska M, Chajduk E, Polkowska-Motrenko H, et al
    Systemic iron deficiency does not affect the cardiac iron content and progression of heart failure.
    J Mol Cell Cardiol. 2021;159:16-27.
    PubMed     Abstract available
    
    
    
61. WANG X, Lupton C, Lauth A, Wan TC, et al
    Evidence that the acetyltransferase Tip60 induces the DNA damage response and cell-cycle arrest in neonatal cardiomyocytes.
    J Mol Cell Cardiol. 2021;155:88-98.
    PubMed     Abstract available
    
    
    April 2021
62. WAN R, Yuan P, Guo L, Shao J, et al
    Ubiquitin-like protein FAT10 suppresses SIRT1-mediated autophagy to protect against ischemic myocardial injury.
    J Mol Cell Cardiol. 2021;153:1-13.
    PubMed     Abstract available
    
    
    March 2021
63. HESSE M, Bednarz R, Carls E, Becker C, et al
    Proximity to injury, but neither number of nuclei nor ploidy define pathological adaptation and plasticity in cardiomyocytes.
    J Mol Cell Cardiol. 2021;152:95-104.
    PubMed     Abstract available
    
    
    February 2021
64. KAYVANPOUR E, Gi WT, Sedaghat-Hamedani F, Lehmann DH, et al
    microRNA neural networks improve diagnosis of acute coronary syndrome (ACS).
    J Mol Cell Cardiol. 2021;151:155-162.
    PubMed     Abstract available
    
    
    
65. XING W, Tan Y, Li K, Tian P, et al
    Upregulated hepatokine fetuin B aggravates myocardial ischemia/reperfusion injury through inhibiting insulin signaling in diabetic mice.
    J Mol Cell Cardiol. 2021;151:163-172.
    PubMed     Abstract available
    
    
    January 2021
66. AGHAJANIAN A, Zhang H, Buckley BK, Wittchen ES, et al
    Decreased inspired oxygen stimulates de novo formation of coronary collaterals in adult heart.
    J Mol Cell Cardiol. 2021;150:1-11.
    PubMed     Abstract available
    
    
    November 2020
67. ROLLE IG, Crivellari I, Zanello A, Mazzega E, et al
    Heart failure impairs the mechanotransduction propeties of human cardiac pericytes.
    J Mol Cell Cardiol. 2020;151:15-30.
    PubMed     Abstract available
    
    
    September 2020
68. MISTRY P, Reitz CJ, Khatua TN, Rasouli M, et al
    Circadian influence on the microbiome improves heart failure outcomes.
    J Mol Cell Cardiol. 2020 Sep 19. pii: S0022-2828(20)30286.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.